NDC 66220-825

RediTrex

Methotrexate

RediTrex is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Cumberland Pharmaceuticals Inc.. The primary component is Methotrexate.

• Product ID: 66220-825_27143f5b-2401-425a-b0b9-98200d947a35
• NDC: 66220-825
• Product Type: Human Prescription Drug
• Proprietary Name: RediTrex
• Generic Name: Methotrexate
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2020-07-01
• Marketing Category: NDA / NDA
• Application Number: NDA210737
• Labeler Name: Cumberland Pharmaceuticals Inc.
• Substance Name: METHOTREXATE
• Active Ingredient Strength: 25 mg/mL
• Pharm Classes: Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 66220-825-22

4 CARTON in 1 CASE (66220-825-22) > 1 SYRINGE in 1 CARTON (66220-825-11) > 1 mL in 1 SYRINGE

• Marketing Start Date: 2020-07-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "RediTrex" or generic name "Methotrexate"

NDC	Brand Name	Generic Name
66220-815	RediTrex	RediTrex
66220-825	RediTrex	RediTrex
66220-807	RediTrex	RediTrex
66220-810	RediTrex	RediTrex
66220-817	RediTrex	RediTrex
66220-812	RediTrex	RediTrex
66220-820	RediTrex	RediTrex
66220-822	RediTrex	RediTrex
0143-9367	Methotrexate	Methotrexate
0143-9516	Methotrexate	Methotrexate
0143-9517	Methotrexate	Methotrexate
0143-9518	Methotrexate	Methotrexate
0143-9519	Methotrexate	Methotrexate
0143-9830	Methotrexate	Methotrexate
0378-0014	Methotrexate	methotrexate
0555-0572	Methotrexate	Methotrexate
0703-3671	Methotrexate	Methotrexate
0703-3675	Methotrexate	Methotrexate
0703-3678	Methotrexate	Methotrexate